tert-Butyl (5S)-5-methyl-1,4-diazepane-1-carboxylate, 98%, 1g

4,4,5,5-Tetramethyl-2-(3-((4-nitrobenzyl)oxy)phenyl)-1,3,2-dioxaborolane, 100mg

butyl[(4-tert-butylphenyl)methyl]amine, 95.0%, 2g

4-(Trifluoromethyl)benzylamine, 98.0%, 1g

1-(3-Bromo-5-iodophenyl)ethan-1-one, 98%, 250mg

Estándar de viscosidad N250, ROTI®Calipure, 790 cSt (20 °C), 500 ml, envase de vidrio

2-BROMO-5-FLUORO-4-NITROPYRIDINE, 95.0%, 100mg

4-OXO-3,4-DIHYDROQUINAZOLINE-7-CARBOXAMIDE, 95.0%, 250mg

3-(trifluoromethyl)-1H-indol-6-amine hydrochloride, 95.0%, 250mg

Sodium sulfate decahydrate, 99.0%, 5kg

2,4-DICHLORO-5-FLUOROQUINOLINE, 95%, 100mg

3,4,6,7,8,9-Hexahydropyrazino[1,2-a]indol-1(2H)-one, 98+%, 250mg

4-(3,4-Methylenedioxyphenyl)-3-thiosemicarbazide, 2g